Are we missing the target? Are we aiming too low? What are the aerobic exercise prescriptions and their effects on markers of cardiovascular health and systemic inflammation in patients with knee osteoarthritis? A systematic review and meta-analysis by Schulz, Jenna M. et al.
Western University 
Scholarship@Western 
Physiology and Pharmacology Publications Physiology and Pharmacology Department 
7-1-2020 
Are we missing the target? Are we aiming too low? What are the 
aerobic exercise prescriptions and their effects on markers of 
cardiovascular health and systemic inflammation in patients with 
knee osteoarthritis? A systematic review and meta-analysis 
Jenna M. Schulz 
Western University 
Trevor B. Birmingham 
Western University 
Hayden F. Atkinson 
Western University 
Emilie Woehrle 
Western University 
Codie A. Primeau 
Western University 
See next page for additional authors 
Follow this and additional works at: https://ir.lib.uwo.ca/physpharmpub 
 Part of the Medical Physiology Commons, and the Pharmacy and Pharmaceutical Sciences Commons 
Citation of this paper: 
Schulz, Jenna M.; Birmingham, Trevor B.; Atkinson, Hayden F.; Woehrle, Emilie; Primeau, Codie A.; Lukacs, 
Michael J.; Al-Khazraji, Baraa K.; Khan, Michaela C.M.; Zomar, Bryn O.; Petrella, Robert J.; Beier, Frank; 
Appleton, C. Thomas; Shoemaker, J. Kevin; and Bryant, DIanne M., "Are we missing the target? Are we 
aiming too low? What are the aerobic exercise prescriptions and their effects on markers of 
cardiovascular health and systemic inflammation in patients with knee osteoarthritis? A systematic 
review and meta-analysis" (2020). Physiology and Pharmacology Publications. 115. 
https://ir.lib.uwo.ca/physpharmpub/115 
Authors 
Jenna M. Schulz, Trevor B. Birmingham, Hayden F. Atkinson, Emilie Woehrle, Codie A. Primeau, Michael J. 
Lukacs, Baraa K. Al-Khazraji, Michaela C.M. Khan, Bryn O. Zomar, Robert J. Petrella, Frank Beier, C. 
Thomas Appleton, J. Kevin Shoemaker, and DIanne M. Bryant 
This article is available at Scholarship@Western: https://ir.lib.uwo.ca/physpharmpub/115 
   1 of 7Schulz JM, et al. Br J Sports Med 2020;54:771–775. doi:10.1136/bjsports-2018-100231
Are we missing the target? Are we aiming too low? 
What are the aerobic exercise prescriptions and their 
effects on markers of cardiovascular health and 
systemic inflammation in patients with knee 
osteoarthritis? A systematic review and meta- analysis
Jenna M Schulz,1,2 Trevor B Birmingham   ,1,2 Hayden F Atkinson,1,2 Emilie Woehrle,3 
Codie A Primeau,1,2 Michael J Lukacs,1,2 Baraa K Al- Khazraji,2,3 Michaela C M Khan,2,3 
Bryn O Zomar,1,2 Robert J Petrella,2,4 Frank Beier,2,5 C Thomas Appleton,2,6 
J Kevin Shoemaker,2,3 Dianne M Bryant1,2 
Review
To cite: Schulz JM, 
Birmingham TB, Atkinson HF, 
et al. Br J Sports Med 
2020;54:771–775.
 ► Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bjsports- 2018- 100231).
1Health and Rehabilitation 
Sciences, Western University 
Faculty of Health Sciences, 
London, Ontario, Canada
2Bone and Joint Institute, 
Western University, London, 
Ontario, Canada
3Kinesiology, Western University 
Faculty of Health Sciences, 
London, Ontario, Canada
4Family Medicine, Western 
University Schulich School of 
Medicine and Dentistry, London, 
Ontario, Canada
5Physiology and Pharmacology, 
Western University Schulich 
School of Medicine and 
Dentistry, London, Ontario, 
Canada
6Medicine, Western University 
Schulich School of Medicine 
and Dentistry, London, Ontario, 
Canada
Correspondence to
Dr Trevor B Birmingham, Faculty 
of Health Sciences, Bone and 
Joint Institute, London, ON N6G 
1H1, Canada;  tbirming@ uwo. ca
Accepted 17 November 2019
Published Online First 
17 December 2019
© Author(s) (or their 
employer(s)) 2020. No 
commercial re- use. See rights 
and permissions. Published 
by BMJ.
ABSTRACT
Objectives We systemically reviewed published studies 
that evaluated aerobic exercise interventions in patients 
with knee osteoarthritis (OA) to: (1) report the frequency, 
intensity, type and time (FITT) of exercise prescriptions 
and (2) quantify the changes in markers of cardiovascular 
health and systemic inflammation.
Data sources PubMed, CINAHL, Scopus; inception to 
January 2019.
Eligibility criteria Randomised clinical trials (RCT), 
cohort studies, case series.
Design We summarised exercise prescriptions for 
all studies and calculated effect sizes with 95% CIs 
for between- group (RCTs that compared exercise and 
control groups) and within- group (pre- post exercise) 
differences in aerobic capacity (VO2), heart rate (HR), 
systolic blood pressure (SBP), diastolic blood pressure 
(DBP) and inflammatory markers (interleukin-6 (IL-6), 
tumour necrosis factor- alpha). We pooled results where 
possible using random effects models.
Results Interventions from 49 studies were 
summarised; 8% (4/49) met all FITT guidelines; 16% 
(8/49) met all or most FITT guidelines. Fourteen studies 
(10 RCTs) reported at least one marker of cardiovascular 
health or systemic inflammation. Mean differences (95% 
CI) indicated a small to moderate increase in VO2 (0.84 
mL/min/kg; 95% CI 0.37 to 1.31), decrease in HR (−3.56 
beats per minute; 95% CI −5.60 to −1.52) and DBP 
(−4.10 mm Hg; 95% CI −4.82 to −3.38) and no change 
in SBP (−0.36 mm Hg; 95% CI −3.88 to 3.16) and IL-6 
(0.37 pg/mL; 95% CI −0.11 to 0.85). Within- group 
differences were also small to moderate.
Conclusions In studies of aerobic exercise in patients 
with knee OA, very few interventions met guideline- 
recommended dose; there were small to moderate 
changes in markers of cardiovascular health and no 
decrease in markers of systemic inflammation. These 
findings question whether aerobic exercise is being used 
to its full potential in patients with knee OA.
PROSPERO registration number CRD42018087859.
InTRODuCTIOn
The burden of knee osteoarthritis (OA) is substantial 
and growing.1 Patients with knee OA have multiple 
comorbidities including obesity, cardiovascular 
disease, diabetes and metabolic syndrome.1–4 Knee 
OA is associated with cardiovascular events and 
all- cause mortality.5 6 Mechanisms of OA progres-
sion include chronic low- grade inflammation, 
vascular endothelial dysfunction and metabolic 
disturbances.2 7–9 Markers of systemic inflammation 
are associated with increased knee OA structural 
progression and increased pain.10–12
Given the well- established effects of aerobic 
exercise on cardiovascular health and systemic 
inflammation,13 14 there is strong rationale for its 
therapeutic use in patients with knee OA. Aerobic 
exercise is recommended for chronic diseases 
because of its ability to improve multiple physio-
logical impairments,13 15 16 and does so in a dose- 
related manner; higher frequency and intensity 
of exercise improves cardiovascular health,17 18 
expends calories19 and reduces chronic inflamma-
tion.20 21 The American College of Sports Medicine 
(ACSM) provides guidelines for aerobic exercise 
prescription expressed as the frequency, intensity, 
type and time (FITT) principle (online supplemen-
tary table 1).22
Exercise programmes of various types (ie, 
aerobic, strength, neuromuscular) reduce pain and 
increase function immediately after treatment in 
patients with knee OA,23 24 but the effects of aerobic 
exercise beyond musculoskeletal outcomes are 
unclear.23 25 Despite strong physiological rationale 
for aerobic interventions, the exercise prescriptions 
and changes in markers of cardiovascular health 
and systemic inflammation have not been systemat-
ically reviewed in patients with knee OA.
Therefore, we systemically reviewed published 
studies in patients with knee OA that evaluated the 
effect of aerobic exercise interventions to: (1) report 
the exercise prescriptions according to the FITT 
principle and (2) quantify the changes in markers of 
cardiovascular health and systemic inflammation.
METhODS
Protocol and registration
This study conformed to Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses 
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methodological guidelines26 and the Cochrane Handbook27 and 
has been registered in PROSPERO.
Eligibility criteria
We included randomised clinical trials (RCT), cohort studies 
and case series that evaluated an aerobic exercise intervention 
(strictly aerobic or mixed interventions that included an aerobic 
portion) in patients diagnosed with knee OA (tibiofemoral and/
or patellofemoral; unilateral and/or bilateral). The interven-
tions were considered aerobic as defined by ACSM; a mode of 
physical activity that results in improvement and maintenance 
of cardiorespiratory function, including walking, running, 
swimming, cycling and dancing.22 Studies must have compared 
outcome measures to a control group (between- group) or pre- 
post aerobic exercise (within- group).
Search
We searched PubMed, CINAHL and Scopus from database 
inception to January 2019. The search terms included [Osteo-
arthritis AND (knee OR knees OR knee joint OR knee joints) 
AND (exercise OR aerobic OR walk OR walking OR run OR 
running OR cycle OR cycling OR jog OR jogging OR swim OR 
swimming OR dance OR dancing)]. Additionally, we manu-
ally searched reference lists from previous systematic reviews. 
Studies were restricted to those written in either English or 
French. Eight reviewers (four pairs) independently examined 
one- quarter of the titles and abstracts and classified each to 
exclude or retrieve for full- text review, using Covidence (Covi-
dence systematic review software, Veritas Health Innovation, 
Melbourne, Australia, www. covidence. org). The same eight 
reviewers independently assessed full- text articles for eligibility. 
One reviewer (JMS) instructed all other reviewers on study eligi-
bility (titles, abstracts and full- text review) and data extraction 
procedures. If the decision regarding eligibility differed among 
any pair, the same reviewer (JMS) consulted with the pair to 
reach consensus.
Data extraction
Each reviewer individually extracted data for: study design, age, 
sex, body mass index (BMI), OA diagnosis (ie, radiographic and 
Kellgren and Lawrence grade if provided and/or symptomatic 
OA) and characteristics of the exercise programme including 
type of exercise, frequency (sessions/week), intensity (heart 
rate (%HRmax)/aerobic capacity (%VO2max)/heart rate reserve 
(%HRR)/rating of perceived exertion), time (minutes/session, 
including warm- up and cool down), duration of intervention 
(number of weeks), presence of a supervisor and the extent to 
which ACSM criteria were met.
For studies that reported a marker of cardiovascular health or 
systemic inflammation, we extracted the method used to assess 
the outcome and associated statistics for preintervention and 
postintervention scores in all groups (and subgroups) involved. 
For all studies, unadjusted mean differences (MD) were 
extracted, unless reported otherwise (two RCTs28 29 reported 
adjusted means). Reported markers of cardiovascular health 
included VO2 (mL/min/mm Hg), HR (beats per minute; bpm), 
systolic blood pressure (SBP; mm Hg) and diastolic blood pres-
sure (DBP; mm Hg). Reported markers of systemic inflammation 
included interleukin-6 (IL-6; pg/mL) and tumour necrosis factor- 
alpha (TNF-α; pg/mL). Additionally, as the 6 min walk test 
(6MWT (metres)) is a measure of cardiorespiratory fitness and 
musculoskeletal health, we evaluated it separately and included 
it in online supplementary appendix 1. Study authors were 
contacted if additional data were required, and manual estimates 
from figures were obtained if insufficient data were provided.
Risk of bias
We used the Cochrane Risk of Bias tool and the Risk of Bias 
in Non- randomized Studies of Interventions to rate the quality 
of RCTs and non- RCTs, respectively.30 31 The reviewers inde-
pendently assessed each study using the same procedures 
described above, so that risk of bias for each study was rated by 
two reviewers and the same third reviewer (JMS) consulted to 
reach consensus for any discrepancies. Quality of the studies was 
ranked as ‘low’, ‘some’ and ‘high’ bias based on the following 
study design factors: randomisation, deviations from intended 
interventions, missing outcome data, measurement of outcome 
and selection of the reported result. Additionally, bias due to 
confounding, in the selection of participants and in the classifi-
cation of the intervention, was rated for non- RCTs. An overall 
risk rating for the study was estimated from the individual risks 
of each domain. A weighted kappa (κw) for inter- rater agreement 
was calculated for each pair of reviewers before discrepancies 
were resolved (SPSS V.23, IBM). We also used the Grading of 
Recommendations Assessment, Development and Evaluation 
(GRADE) to rate the overall quality of evidence in the system-
atic reviews,32 and the Template for Intervention Descrip-
tion and Replication to aid in the description of the exercise 
interventions.33
Synthesis of results
We calculated the raw MD and 95% CIs for each study and 
pooled data using random effects meta- analyses. We first anal-
ysed between- group differences (ie, aerobic exercise intervention 
vs control) from RCTs. We then analysed within- group (ie, pre- 
post aerobic exercise) paired differences for all study designs. All 
but one study28 provided preintervention and postintervention 
or change data.
When not reported, the SD was estimated from the SE of 
the mean, 95% CI, p value or other methods suggested in the 
Cochrane Handbook.27 Means and SDs were estimated from 
median and range for two studies.34 Following Cochrane guide-
lines, for any study that included two different intervention 
groups (ie, cycling vs walking) and one control group, the sample 
size in the control group was evenly divided so a comparison 
could be made to each intervention.27 We imputed r=0.5 when 
the correlation of prescores and postscores was required and 
we performed sensitivity analyses using r values ranging from 
0.1 to 0.9.35 36 Heterogeneity was examined using the I2 statistic 
and p values, where an absence of inconsistency was repre-
sented as 0%, less than 40% was considered low, 30%–60% was 
moderate, 50%–90% was substantial, 75%–100% was consid-
erable and 100% indicated maximal inconsistency (ie, high 
heterogeneity).37 Additional subgroup and sensitivity analyses 
were planned based on a priori hypotheses described in online 
supplementary appendix 1. Meta- analyses were performed using 
Comprehensive Meta- Analysis software program (V.3, Biostat).
RESulTS
Study selection
Our electronic search yielded 5857 studies with 244 eligible for 
full- text review. Forty- nine studies met our eligibility criteria for 
objective 1, review of exercise prescriptions (figure 1).28 29 38–83 
Twenty- three RCTs compared an aerobic exercise group to a non- 
exercising control group, 15 RCTs compared groups completing 
different types of exercise and 11 studies compared outcomes 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- 
Analyses (PRISMA) flow chart of included and excluded studies.
before and after aerobic exercise in one group. Fourteen studies 
reported a marker of cardiovascular health and/or systemic 
inflammation and were included in various meta- analyses. For 
between- group analyses, 10 RCTs that included a control group 
were included (online supplementary table 2). Four studies 
compared VO2, three compared HR, two compared SBP and 
DBP and three compared IL-6. For within- group analyses, all 
study types were included. In total, five studies reported VO2, 
four reported HR, three reported SBP and DBP, five reported 
IL-6 and four reported TNF-α (online supplementary table 3).
Participant and intervention characteristics
A total of 3448 patients were included for objective 1 (76% 
female, age=63±7 years; BMI=29.3±4.9 kg/m2; mean±SD). 
Three studies39 40 44 where patients had OA at multiple joints 
were included because over 60% of the participants had knee 
OA (online supplementary table 2).
Comparison to ACSM guidelines for aerobic exercise
Interventions in 2 of the 49 studies (4%) met all domains of 
the ACSM FITT criteria, and another two46 64 met the criteria 
progressively over time, whereby the duration (ie, minutes/
session) and/or intensity (ie, %HRmax/VO2max) increased as the 
intervention advanced forward. Therefore, all domains were 
met by the end of the intervention (4/49, 8%). Interventions 
in another four studies (8%)29 69 70 72 met three of the FITT 
criteria recommended by ACSM, with the exception of 150 
min of aerobic exercise/week. Therefore, 8/49 (16%) met all or 
most of the criteria. All exercise interventions were classified as 
moderate intensity (or less) according to ACSM criteria (online 
supplementary table 1). The overall average patient adherence to 
the intervention was 86%, measured by attendance or dropout 
(online supplementary table 3).
Risk of bias
There was substantial agreement on items with the exception 
of bias in the selection of participants and bias in the reporting 
of results for non- RCTs, requiring the third reviewer to reach 
consensus (p<0.05, κw ranging from 0.13 to 0.75). For RCTs, 
45% (17/38) of studies had ‘high’ risk for measurement bias. 
Most studies had ‘low’ or ‘some’ risk for selection, performance 
and detection bias. All non- RCTs had a high risk of bias for 
confounding, and most (8/11, 72%) had a high risk for inter-
vention classification. Patient and personnel blinding was not 
possible in all studies; however, most had inappropriate methods 
to control for confounding variables or did not blind outcome 
assessors. All studies had a ‘low’ risk for participant selection 
bias, because selection was not based on characteristics observed 
after the start of the study. Overall, most studies (36/49, 74%) 
had a ‘high’ risk of bias, 9 (18%) had a ‘low’ risk of bias and 
4 (8%) had ‘some’ risk of bias (online supplementary table 3, 
online supplementary figure 1). Additionally, all studies rated 
low in the quality of evidence according to GRADE.
Markers of cardiovascular health and systemic inflammation
Synthesis of results comparing aerobic exercise to control
Between- group (RCT) analyses (MD, 95% CI) indicated a statis-
tically significant increase in VO2 (0.84 mL/min/kg; 95% CI 0.37 
to 1.3), decrease in HR (−3.56 bpm; 95% CI −5.60 to –1.52) 
and decrease in DBP (−4.10 mm Hg; 95% CI −4.82 to –3.38), 
p<0.05 (figure 2A,B,D). There were no statistically significant 
differences in SBP (−0.36 mm Hg; 95% CI –3.88 to 3.16) and 
IL-6 (0.37 pg/mL; 95% CI −0.11 to 0.85); p>0.05 (figure 2C,E).
Synthesis of results comparing pre-aerobic to post-aerobic exercise
The within- group (pre- post exercise) analyses indicated a statis-
tically significant increase in VO2 (1.69 mL/min/kg; 95% CI 
0.51 to 2.87), decrease in HR (−4.54 bpm; 95% CI −6.82 to 
–2.25) and decrease in SBP (−7.19 mm Hg; 95% CI −11.40 
to –2.25) and DBP (−4.66 mm Hg; 95% CI −6.03 to –3.28) 
(online supplementary appendix 1; figure 2A–D). There was 
no statistically significant change in IL-6 (−0.09 pg/mL; 95% 
CI −0.63 to 0.44, p>0.05) (online supplementary appendix 1; 
figure 2E) and a statistically significant increase in TNF-α (0.99 
pg/mL; 95% CI 0.21 to 1.77, p<0.05) (online supplementary 
appendix 1; figure 2F).
Results for additional analyses including 6MWT are reported in 
online supplementary appendix 1 (figure 3). Results of subgroup 
and sensitivity analyses were generally consistent with the primary 
analysis(online supplementary appendix 1; table 4).
DISCuSSIOn
What are the aerobic exercise prescriptions studied in 
patients with knee OA?
Only 16% (8/49) of published studies in patients with knee 
OA evaluated interventions that met all or most of the ACSM 
guidelines for aerobic exercise prescription. Most interven-
tions reviewed (45/49, 92%) did not meet the target of 150 
min/week of moderate to vigorous activity. Additionally, most 
studies (40/49, 82%) did not measure HR or VO2 to ensure 
patients were exercising at the target intensity. Several exercise 
programmes (22/49, 45%) were less than 12 weeks; durations 
ranged from 4 to 78 weeks (online supplementary table 2). Most 
studies had a ‘high’ risk of bias (online supplementary table 3, 
online supplementary figure 1); and all studies rated low in the 
quality of evidence according to GRADE.
Why are the interventions not meeting recommended dose?
We suggest the likely reasons the studied interventions did not 
strictly follow aerobic exercise guidelines include the perceived 
lack of ability for patients with knee OA to adhere to the guide-
lines, the fear of exacerbating symptoms and increasing adverse 
events and/or the desire to limit patients from dropping out. While 
well accepted as providing the physiological dose required to evoke 
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Figure 2 Forest plot of between- group analyses (ie, randomised clinical trials (RCT); exercise vs control) for the following outcomes: aerobic 
capacity (VO2, A); heart rate (HR, B); systolic blood pressure (SBP, C); diastolic blood pressure (DBP, D); and interleukin-6 (IL-6, E). Weights are from a 
random effects analysis. Overall effects are shown as mean difference (MD) with 95% CI. N, number of patients.
improvements in cardiovascular health and chronic inflammation, 
the FITT guidelines are not disease specific. Therefore, patients 
and their health providers must adjust guideline parameters to meet 
individual patient needs.84 Other recently published meta- analyses 
suggest that patients with knee OA do not experience increased 
pain with exercise,24 and that knee loading with exercise is not 
harmful to the articular cartilage.85 Therefore, published exercise 
prescription guidelines are recommended to guide exercise inter-
ventions for people with OA.86
Aerobic exercise in patients for other chronic diseases has 
been able to meet ACSM guidelines. In patients with type 2 
diabetes, higher intensities of aerobic exercise resulted in greater 
improvements in cardiorespiratory fitness.87 A recent systematic 
review of the effects of aerobic exercise for patients with meta-
bolic syndrome only included studies with interventions that met 
the FITT criteria. It reported substantial improvements in HR, 
SBP and VO2, with vigorous intensity interventions providing 
greater effects.88
What are the effects on markers of cardiovascular health and 
systemic inflammation?
Only 14 of the studies (29%) evaluated the effects of aerobic 
exercise using a marker of cardiovascular health or systemic 
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inflammation. Meta- analyses of those results indicated only 
small to moderate improvements in VO2, HR and DBP (online 
supplementary appendix 1; figure 2). Although some of these 
improvements may arguably be clinically important, they are 
less than typically observed following aerobic exercise interven-
tions and are likely to fall short in evoking optimal effects for 
patients with knee OA. As administered in the studies reviewed, 
the aerobic exercise interventions did not decrease circulating 
inflammatory factors IL-6 and TNF-α (online supplementary 
appendix 1; figure 2).
When ACSM guideline- recommended dose is met, aerobic 
exercise can markedly improve cardiovascular health,89 90 
decrease systemic inflammation91 92 and increase caloric expen-
diture.19 Such physiological outcomes have potential to affect 
multiple disease processes linked to OA93–95 and may be reason-
ably hypothesised to decrease the risk of progression of knee 
OA and associated comorbidities. The caveat lies in the proper 
administration and adherence to aerobic exercise guidelines. 
Importantly, as suggested by the present data, when patients with 
OA are not meeting recommended guidelines, optimal improve-
ments in cardiovascular health and systemic inflammation do 
not occur. Without such physiological changes, there may be 
no concomitant improvement in OA progression or comorbid-
ities, and improvements in pain and function may be less than 
possible. Therefore, the true potential of aerobic exercise as a 
treatment for knee OA may be unrealised.
It is important to acknowledge that despite not meeting ACSM 
guidelines, the interventions were generally well attended by 
patients and did provide small to moderate improvements in 
some markers of cardiovascular health (online supplementary 
appendix 1; figure 2). As studied, the interventions also provided 
moderate improvements in the 6MWT (online supplementary 
appendix 1; figure 3).The results of the present review do not 
negate the importance of encouraging patients with knee OA 
to exercise, even at lower levels than those suggested to evoke 
optimal changes in cardiovascular health and systemic inflamma-
tion, given the other health benefits of physical activity.24 96–99
limitations
The present estimates of the within- group pre- post exercise 
changes (online supplementary appendix 1; figure 2) should be 
interpreted carefully. For these analyses, the true intervention 
effects may not be discernible from effects caused by the simple 
passage of time, measurement error and/or characteristics of 
the patients and setting.100 Similarly, including non- randomised 
studies may contribute to uncontrolled confounding. Regardless, 
our between- group and within- group comparisons reveal lower 
changes in cardiovascular health and systemic inflammation than 
previously observed in randomised trials of aerobic exercise in 
patients with other chronic diseases.87 88
The present methods used to determine effect sizes assume 
normally distributed outcomes within each study and this may 
not always be the case, especially for the several relatively small 
studies included in this review. Moreover, although studies 
reported the same markers, pooled data across all studies were 
sometimes assessed using slightly different methods (ie, calcu-
lated max vs peak VO2, using a treadmill protocol vs cycling 
protocol, and so on). While we reported individual and pooled 
study effect sizes, and performed sensitivity analyses where 
possible, results may differ based on study methods. Lastly, 
few studies reported sex- specific analyses. These should be 
performed in future, adequately powered studies.
COnCluSIOnS
Despite the strong rationale to improve cardiovascular health 
and reduce systemic inflammation in patients with knee OA, 
published studies include aerobic exercise interventions that 
rarely meet recommended dose guidelines. The pooled results 
from studies reporting a marker of cardiovascular health or 
systemic inflammation suggest only small to moderate effects on 
VO2, HR and blood pressure and no decrease in inflammatory 
markers. Therefore, clinicians may not be extracting the full 
potential benefit of aerobic exercise in patients with knee OA. 
Whether this is the case or not needs to be studied.
What is already known
 ► Knee osteoarthritis (OA) is associated with systemic 
inflammation, cardiovascular events and all- cause mortality.
 ► Aerobic exercise improves cardiovascular health and reduces 
systemic inflammation—this is a strong rationale for its use 
in patients with knee OA.
What are the new findings
 ► In studies of aerobic exercise in patients with knee OA, the 
interventions did not meet recommended exercise dose; 
postexercise anticipated increase in VO2 and decreases 
in heart rate and blood pressure were small to moderate; 
there was no decrease in systemic inflammatory markers 
interleukin-6 and tumour necrosis factor- alpha.
 ► The therapeutic effects of aerobic exercise in patients 
with knee OA remain unclear. We encourage studies of 
interventions that evoke more substantial changes in 
cardiovascular health and systemic inflammation.
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